Development and characterization of HBsAg-loaded Eudragit nanoparticles for effective colonic immunization

References

• Akhgari A, Garekani HA, Sadeghi F, Azimaie M. 2005. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharmaceutics. 305:22–30.
   PubMed Web of Science ®Google Scholar
• Araujo J, Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. 2010. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm. 393:168–176.
   Web of Science ®Google Scholar
• Beck-Broichsitter M, Nicolas J, Couvreur P. 2015. Solvent selection causes remarkable shifts of the “Ouzo region” for poly(lactide- co-glycolide) nanoparticles prepared by nanoprecipitation. Nanoscale. 7:9215–9221.
   PubMed Web of Science ®Google Scholar
• Chuang EY, Lin KJ, Su FY, Mi FL, Maiti B, Chen CT, Wey SP, Yen TC, Juang JH, Sung HW. 2013. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats. J Control Release. 172:513–522.
   PubMed Web of Science ®Google Scholar
• Damge C, Socha M, Ubrich N, Maincent P. 2010. Poly(e-Caprolactone)/Eudragit nanoparticles for oral delivery of Aspart-Insulin in the treatment of diabetes. J Pharm Sci. 99:879–889.
   PubMed Web of Science ®Google Scholar
• Dewangan HK, Singh S. 2016. Application of central composite design in the preparation and optimization of poly(lactic-coglycolic acid) nanoparticles for systemic immune responses of Hepatitis B antigen. Pharm Anal Acta. 7:156.
   Google Scholar
• Durowoju IB, Bhandal KS, Hu J, Carpick B, Kirkitadze M. 2017. Differential scanning calorimetry — a method for assessing the thermal stability and conformation of protein antigen. J Vis Exp. 121:1–8.
   Google Scholar
• Eldridge JH, Staas JK, Meulbroek JA, McGhee JR, Tice TR, Gilley RM. 1991. Biodegradable microspheres as a vaccine delivery system. Mol Immunol. 28:287–294.
   PubMed Web of Science ®Google Scholar
• Endmann A, Klunder K, Kapp K, Riede O, Oswald D, Talman EG, Schroff M, Kleuss C, Ruiters MHJ, Juhls C. 2014. Cationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccine. PLoS One. 9:1–10.
   Web of Science ®Google Scholar
• Grohmann FL, Szógyi M, Csempesz F. 1997. Interaction of lipid membranes and neutral polymers by differential scanning calorimetry (DSC). Acta Pharm Hung. 67:267–272.
   PubMedGoogle Scholar
• Han F, Li S, Yin R, Liu H, Xu L. 2008. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers. Colloids Surf A. 315:210–216.
   Web of Science ®Google Scholar
• Hayden CA, Smith EM, Turner DD, Keener TK, Wong JC, Walker JH, Tizard IR, Jimenez-Flores R, Howard JA. 2014. Supercritical fluid extraction provides an enhancement to the immune response for orally-delivered hepatitis B surface antigen. Vaccine. 32:1240–1246.
   PubMed Web of Science ®Google Scholar
• Hemling ME, Carr SA, Capiau C, Petre J. 1988. Structural characterization of recombinant hepatitis B surface antigen protein by mass spectrometry. Biochemistry. 27:699–705.
   PubMed Web of Science ®Google Scholar
• Hordnes K, Digranes A, Hauten LL, Helland DE, Ulstein M, Jonsson R, Haneberg B. 1995. Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa. J Reprod Immunol. 28:247–262.
   PubMed Web of Science ®Google Scholar
• Jain AK, Goyal AK, Mishra N, Vaidya B, Mangal S, Vyas SP. 2010. PEG–PLA–PEG block copolymeric nanoparticles for oral immunization against hepatitis B. Int J Pharmaceutics. 387:253–262.
   PubMed Web of Science ®Google Scholar
• Jain D, Panda AK, Majumdar DK. 2005. Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech. 6:E100–E107.
   PubMed Web of Science ®Google Scholar
• Karthikeyan K, Guhathakarta S, Rajaram R, Korrapati PS. 2012. Electrospun zein/eudragit nanofibers based dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole. Int J Pharma. 438:117–122.
   PubMed Web of Science ®Google Scholar
• Khan MZI, Prebeg Z, Kurjakovic N. 1999. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers I. Manipulation of drug release using Eudragit® L100-55 and Eudragit® S100 combinations. J Control Release. 58:215–222.
   PubMed Web of Science ®Google Scholar
• Lason E, Sikora E, Ogonowski J. 2013. Influence of process parameters on properties of nanostructured lipid carriers (NLC) formulation. Acta Biochim Pol. 60:773–777.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tseng YC, Huang L. 2012. Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?. Pharm Res. 12:3273–3277.
   Google Scholar
• Maheshwari C, Pandey RS, Chaurasiya A, Kumar A, Selvam DT, Prasad GB, Dixit VK. 2011. Non-ionic surfactant vesicles mediated transcutaneous immunization against hepatitis B. Int Immunopharm. 11:1516–1522.
   PubMed Web of Science ®Google Scholar
• Pandey RS, Dixit VK. 2009. Evaluation of ISCOMs for immunization against hepatitis B. Curr Pharm Biotechnol. 10:709–716.
   PubMed Web of Science ®Google Scholar
• Pandey RS, Dixit VK. 2010. Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B. J Drug Target. 18:282–291.
   PubMed Web of Science ®Google Scholar
• Pham W, Xie J, Gore JC. 2007. Tracking the migration of dendritic cells by in vivo optical imaging. Neoplasia. 9:1130–1137.
   PubMed Web of Science ®Google Scholar
• Pirouzmand H, Khameneh B, Tafaghodi M. 2017. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid. Pharm Biol. 55:212–217.
   PubMed Web of Science ®Google Scholar
• Pradhan M, Singh D, Singh MR. 2015. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis. Chem Phys Lipids. 86:9–16.
   Google Scholar
• Reda RI, Wen MM, El-Kamel AH. 2017. Ketoprofen-loaded Eudragit electrospun nanofibers for the treatment of oral mucositis. Int J Nanomed. 12:2335–2351.
   PubMed Web of Science ®Google Scholar
• Sahu KK, Pandey RS. 2016. Immunological evaluation of colonic delivered hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles. Int Immunopharma. 39:3–352.
   Web of Science ®Google Scholar
• Saupe A, Rades T. 2006. Solid lipid nanoparticle. In: Mozafari MR, editor. Nanocarrier technologies: frontiers of nanotherapy. Dordrecht: Springer; p. 41–50.
   Google Scholar
• Sharma VK, Jain A, Soni V. 2013. Nano-aggregates: emerging delivery tools for tumor therapy. Crit Rev Ther Drug Carrier Syst. 30:535–563.
   PubMed Web of Science ®Google Scholar
• Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. 2006. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 28:112–125.
   PubMed Web of Science ®Google Scholar
• Shukla A, Katare OP, Singh B, Vyas SP. 2010. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm. 385:47–52.
   PubMed Web of Science ®Google Scholar
• Souder JC, Ellenbogen WC. 1985. Control of d-amphetamine sulphate sustained release capsule. Drug Stand. 26:77–79.
   Google Scholar
• Tiwari S, Agrawal GP, Vyas SP. 2010. Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines. Nanomedicine (London). 5:1617–1640.
   PubMed Web of Science ®Google Scholar
• Tleugabulova D. 1998. Sodium dodecylsulfate polyacrylamide gel electrophoresis of recombinant hepatitis B surface antigen particles. J Chromatogr B Biomed Sci Appl. 707:267–273.
   PubMed Web of Science ®Google Scholar
• Tomar P, Karwasara VS, Dixit VK. 2011. Development characterizations and evaluation of Poly(-ε-caprolactone)-based microspheres for hepatitis B surface antigen delivery. Pharm Dev Technol. 16:489–496.
   PubMed Web of Science ®Google Scholar
• Vermeiren A, Hoebe CJ, Dukers-Muijrers NH. 2013. High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. J Clin Virol. 58:262–264.
   PubMed Web of Science ®Google Scholar
• Yamada H, Urata C, Ujiie H, Yamauchi Y, Kuroda K. 2013. Preparation of aqueous colloidal mesostructured and mesoporous silica nanoparticles with controlled particle size in a very wide range from 20 nm to 700 nm. Nanoscale. 5:6145–6153.
   PubMed Web of Science ®Google Scholar
• Yu C, Zhou Q, Xiao F, Li Y, Hu H, Wan Y, Li Z, Yang X. 2017. Enhancing doxorubicin delivery toward tumor by hydroxyethyl starch-g-polylactide partner nanocarriers. ACS Appl Mater Interfaces. 9:10481–10493.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Talton J, Zhang G, Cunningham T, Wang Z, Waters RC, Kirk J, Eppler B, Klinman DM, Sui Y, et al. 2012. Large intestine–targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. Nat Med. 18:1291–1295.
   PubMed Web of Science ®Google Scholar